Combined with our previous work demonstrating the presence of cleaved CXCL10 in tumour tissue [14], our data strongly indicate that these discrepancies relate to the relative levels of biologically active versus modified CXCL10 associated with ovarian tumours. This evidence concerns the gene CXCL10 and neoplasm.